DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SILDENAFIL CITRATE

Clinical Trials for Sildenafil Citrate

Subscribe to access the full database, or try a Free Trial
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00123162	Viagra in the Treatment of Primary Dysmenorrhea	Completed	National Institutes of Health (NIH)	Phase 1/Phase 2	The primary hypothesis is that a 100mg single dose of sildenafil citrate (Viagra) will have a higher improvement rate when compared to placebo in the treatment of moderate to severe primary dysmenorrhea.
NCT00123162	Viagra in the Treatment of Primary Dysmenorrhea	Completed	Milton S. Hershey Medical Center	Phase 1/Phase 2	The primary hypothesis is that a 100mg single dose of sildenafil citrate (Viagra) will have a higher improvement rate when compared to placebo in the treatment of moderate to severe primary dysmenorrhea.
NCT00141310	Sildenafil Citrate for the Treatment of Established Pre-Eclampsia	Terminated	Pfizer	Phase 2	To determine the efficacy and safety of sildenafil citrate in the treatment of established pre-eclampsia
NCT00142506	Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer	Completed	Beth Israel Medical Center	Phase 3	Radiation sometimes affects the ability for a person to have a normal erection. Complete loss of erections after radiation treatment can happen in 40-50% of treated patients. There are medications, like sildenafil (also known as Viagra), that can help the ability to get back erections in almost 70% of such patients. The purpose of this study is to see if taking Viagra every day starting right before, during and for about 6 months after treatment, could reduce the risk of long-term erectile dysfunction.
NCT00142506	Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer	Completed	Icahn School of Medicine at Mount Sinai	Phase 3	Radiation sometimes affects the ability for a person to have a normal erection. Complete loss of erections after radiation treatment can happen in 40-50% of treated patients. There are medications, like sildenafil (also known as Viagra), that can help the ability to get back erections in almost 70% of such patients. The purpose of this study is to see if taking Viagra every day starting right before, during and for about 6 months after treatment, could reduce the risk of long-term erectile dysfunction.
NCT00142506	Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer	Completed	St. Luke's-Roosevelt Hospital Center	Phase 3	Radiation sometimes affects the ability for a person to have a normal erection. Complete loss of erections after radiation treatment can happen in 40-50% of treated patients. There are medications, like sildenafil (also known as Viagra), that can help the ability to get back erections in almost 70% of such patients. The purpose of this study is to see if taking Viagra every day starting right before, during and for about 6 months after treatment, could reduce the risk of long-term erectile dysfunction.
Trial ID	Title	Status	Sponsor	Phase	Summary